Trial · NCT03265132
Results by group87
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 87
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of ACR30 Responders With Absence of Fever Attributable to the Disease During the 7 Days Preceding Week 2. | Anakinra | 6 | Participants | ||
| Proportion of ACR30 Responders With Absence of Fever Attributable to the Disease During the 7 Days Preceding Week 2. | Placebo | 0 | Participants | ||
| Proportion of ACR30 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Anakinra | 5 | Participants | ||
| Proportion of ACR30 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Placebo | 3 | Participants | ||
| Proportion of ACR50 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Anakinra | 5 | Participants | ||
| Proportion of ACR50 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Placebo | 2 | Participants | ||
| Proportion of ACR70 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Anakinra | 5 | Participants | ||
| Proportion of ACR70 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Placebo | 0 | Participants | ||
| Proportion of ACR90 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Anakinra | 4 | Participants | ||
| Proportion of ACR90 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Placebo | 0 | Participants | ||
| Proportion of ACR50 Responders With Absence of Fever During 7 Days Preceding Week 2. | Anakinra | 6 | Participants | ||
| Proportion of ACR50 Responders With Absence of Fever During 7 Days Preceding Week 2. | Placebo | 0 | Participants | ||
| Proportion of ACR70 Responders With Absence of Fever During 7 Days Preceding Week 2. | Anakinra | 6 | Participants | ||
| Proportion of ACR70 Responders With Absence of Fever During 7 Days Preceding Week 2. | Placebo | 0 | Participants | ||
| Proportion of ACR90 Responders With Absence of Fever During 7 Days Preceding Week 2. | Anakinra | 5 | Participants | ||
| Proportion of ACR90 Responders With Absence of Fever During 7 Days Preceding Week 2. | Placebo | 0 | Participants | ||
| Proportion of Responders in Physician Global Assessment of Disease Activity. | Anakinra | 4 | Participants | ||
| Proportion of Responders in Physician Global Assessment of Disease Activity. | Placebo | 0 | Participants | ||
| Proportion of Responders in Patient/Parent Global Assessment of Overall Well-being. | Anakinra | 4 | Participants | ||
| Proportion of Responders in Patient/Parent Global Assessment of Overall Well-being. | Placebo | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03265132/results